{
  "DOI": "10.1007/s10689-013-9690-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-013-9690-3",
  "alternative-id": [
    "9690"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Krivokuca",
      "given": "Ana M.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Malisic",
      "given": "Emina J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dobricic",
      "given": "Jelena D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brotto",
      "given": "Ksenija V.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cavic",
      "given": "Milena R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jankovic",
      "given": "Radmila N.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tomasevic",
      "given": "Zorica I.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brankovic-Magic",
      "given": "Mirjana V.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        10,
        9
      ]
    ],
    "date-time": "2013-10-09T08:26:53Z",
    "timestamp": 1381307213000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        7,
        30
      ]
    ],
    "date-time": "2019-07-30T14:58:23Z",
    "timestamp": 1564498703000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        1,
        29
      ]
    ],
    "date-time": "2023-01-29T22:16:06Z",
    "timestamp": 1675030566123
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2013,
        10,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2014,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            10,
            10
          ]
        ],
        "date-time": "2013-10-10T00:00:00Z",
        "timestamp": 1381363200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9690-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-013-9690-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9690-3",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "173-180",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2013,
        10,
        10
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        10,
        10
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2014,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s13402-011-0010-3",
      "author": "P Groep Van der",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "journal-title": "Cell Oncol",
      "key": "9690_CR1",
      "unstructured": "Van der Groep P, Van der Wall E, Van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol 34:71–88",
      "volume": "34",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1471-2407-7-163",
      "author": "S Margolin",
      "doi-asserted-by": "crossref",
      "first-page": "163",
      "journal-title": "BMC Cancer",
      "key": "9690_CR2",
      "unstructured": "Margolin S, Eiberg H, Lindblom A, Bisgaard ML (2007) CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer. BMC Cancer 7:163",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1186/bcr2099",
      "author": "GB Byrnes",
      "doi-asserted-by": "crossref",
      "first-page": "208",
      "journal-title": "Breast Cancer Res",
      "key": "9690_CR3",
      "unstructured": "Byrnes GB, Southey MC, Hopper JL (2008) Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? Breast Cancer Res 10:208",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-0416",
      "author": "O Fletcher",
      "doi-asserted-by": "crossref",
      "first-page": "230",
      "issue": "1",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9690_CR4",
      "unstructured": "Fletcher O, Johnson N, Santos Silva I, Kilpivaara O, Aittomaki K, Blomqvist C et al (2009) Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2*1100delC in 1,828 bilateral breast cancers and 7,030 controls. Cancer Epidemiol Biomarkers Prev 18(1):230–234",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1177/107327480501200210",
      "author": "V Dapic",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "issue": "2",
      "journal-title": "Cancer Control J",
      "key": "9690_CR5",
      "unstructured": "Dapic V, Carvalho MA, Monteiro A (2005) Breast cancer susceptibility and the DNA damage response. Cancer Control J 12(2):127–136",
      "volume": "12",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s10549-006-9364-z",
      "author": "S Costa",
      "doi-asserted-by": "crossref",
      "first-page": "209",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9690_CR6",
      "unstructured": "Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R et al (2007) DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103:209–217",
      "volume": "103",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s100380050199",
      "author": "M Kato",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "journal-title": "J Hum Genet",
      "key": "9690_CR7",
      "unstructured": "Kato M, Yano K, Matsuo F, Saito H, Katagiri T, Kurumizaka F et al (2000) Identification of Rad51 alteration in patients with bilateral breast cancer. J Hum Genet 45:133–137",
      "volume": "45",
      "year": "2000"
    },
    {
      "author": "W Wang",
      "first-page": "955",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9690_CR8",
      "unstructured": "Wang W, Spurdle A, Kolachana P, Bove B, Modan B, Ebbers S et al (2001) A single nucleotide polymorphism in the 5′untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomark Prev 10:955–960",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.cell.2009.04.037",
      "author": "K Vousden",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "journal-title": "Cell",
      "key": "9690_CR9",
      "unstructured": "Vousden K, Prives C (2009) Blinded by the Light: the growing complexity of p53. Cell 137:413–431",
      "volume": "137",
      "year": "2009"
    },
    {
      "DOI": "10.1186/bcr426",
      "author": "M Gasco",
      "doi-asserted-by": "crossref",
      "first-page": "70",
      "journal-title": "Breast Cancer Res",
      "key": "9690_CR10",
      "unstructured": "Gasco M, Shami S, Crook T (2002) The p53 pathway in breast cancer. Breast Cancer Res 4:70–76",
      "volume": "4",
      "year": "2002"
    },
    {
      "DOI": "10.1038/nrc2584",
      "author": "C Whibley",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "journal-title": "Nat Rev",
      "key": "9690_CR11",
      "unstructured": "Whibley C, Pharoah P, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev 9:95–110",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1186/2041-9414-1-15",
      "author": "T Bohgaki",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "Genome Integr",
      "key": "9690_CR12",
      "unstructured": "Bohgaki T, Bohgaki M, Hakem R (2010) DNA double-strand break signaling and human disorders. Genome Integr 1:15",
      "volume": "1",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.canlet.2004.08.009",
      "author": "C Richardson",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "journal-title": "Cancer Lett",
      "key": "9690_CR13",
      "unstructured": "Richardson C (2005) RAD51, genomic stability, and tumorigenesis. Cancer Lett 218:127–139",
      "volume": "218",
      "year": "2005"
    },
    {
      "DOI": "10.1186/bcr1415",
      "author": "F Lose",
      "doi-asserted-by": "crossref",
      "first-page": "R26",
      "journal-title": "Breast Cancer Res",
      "key": "9690_CR14",
      "unstructured": "Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB et al (2006) Variation in the RAD51 gene and familial breast cancer. Breast Cancer Res 8:R26",
      "volume": "8",
      "year": "2006"
    },
    {
      "author": "C Schmutte",
      "first-page": "4564",
      "journal-title": "Cancer Res",
      "key": "9690_CR15",
      "unstructured": "Schmutte C, Tombline G, Rhiem K, Sadoff MM, Schmutzler R, von Deimling A et al (1999) Characterization of the human Rad51 genomic locus and examination of tumors with 15q14–15 loss of heterozygosity (LOH). Cancer Res 59:4564–4569",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1073/pnas.93.13.6236",
      "author": "T Tsuzuki",
      "doi-asserted-by": "crossref",
      "first-page": "6236",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9690_CR16",
      "unstructured": "Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, Sekiguchi M et al (1996) Targeted disruption of the Rad5 l gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA 93:6236–6240",
      "volume": "93",
      "year": "1996"
    },
    {
      "author": "E Raderschall",
      "first-page": "219",
      "journal-title": "Cancer Res",
      "key": "9690_CR17",
      "unstructured": "Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T (2002) Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res 62:219–225",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10549-010-0995-8",
      "author": "LB Gao",
      "doi-asserted-by": "crossref",
      "first-page": "827",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9690_CR18",
      "unstructured": "Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS et al (2011) RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat 125:827–835",
      "volume": "125",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-010-0922-z",
      "author": "H Sun",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9690_CR19",
      "unstructured": "Sun H, Bai J, Chen F, Jin Y, Yu Y, Jin L, Fu S (2011) RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects. Breast Cancer Res Treat 125:157–161",
      "volume": "125",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2007.05.024",
      "author": "L Jara",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "9690_CR20",
      "unstructured": "Jara L, Acevedo M, Blanco R, Castro V, Bravo T, Gomez F et al (2007) RAD51 135G\u003eC polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 178:65–69",
      "volume": "178",
      "year": "2007"
    },
    {
      "DOI": "10.1086/522611",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1186",
      "journal-title": "Am J Hum Genet",
      "key": "9690_CR21",
      "unstructured": "Antoniou A, Sinilnikova O, Simard J, Leone M, Dumon M, Neuhausen S (2007) RAD51 135G\u003eC modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186–1200",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00109-007-0221-2",
      "author": "J Teodoro",
      "doi-asserted-by": "crossref",
      "first-page": "1175",
      "journal-title": "J Mol Med",
      "key": "9690_CR22",
      "unstructured": "Teodoro J, Evans S, Green M (2007) Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med 85:1175–1186",
      "volume": "85",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.jmb.2003.12.050",
      "author": "D Yoon",
      "doi-asserted-by": "crossref",
      "first-page": "639",
      "journal-title": "J Mol Biol",
      "key": "9690_CR23",
      "unstructured": "Yoon D, Wang Y, Stapleford K, Wiesmuller L, Chen J (2004) p53 inhibits strand exchange and replication fork regression promoted by human Rad51. J Mol Biol 336:639–654",
      "volume": "336",
      "year": "2004"
    },
    {
      "author": "A Al-Qasem",
      "first-page": "875",
      "journal-title": "Oncol Lett",
      "key": "9690_CR24",
      "unstructured": "Al-Qasem A, Toulimat M, Tulbah A, Elkum N, Al-Tweigeri T, Aboussekhra A (2012) The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. Oncol Lett 3:875–878",
      "volume": "3",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0047325",
      "author": "K Proestling",
      "doi-asserted-by": "crossref",
      "first-page": "e47325",
      "issue": "10",
      "journal-title": "PLOS",
      "key": "9690_CR25",
      "unstructured": "Proestling K, Hebar A, Pruckner N, Marton E, Vinatzer U, Schreiber M (2012) The pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk. PLOS 7(10):e47325",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6602451",
      "author": "T Ohayon",
      "doi-asserted-by": "crossref",
      "first-page": "1144",
      "journal-title": "Br J Cancer",
      "key": "9690_CR26",
      "unstructured": "Ohayon T, Gershoni-Baruch R, Papa MZ, Distelman Menachem T, Eisenberg Barzilai S, Friedman E (2005) The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer 92:1144–1148",
      "volume": "92",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.cdp.2006.09.007",
      "author": "A Damin",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "journal-title": "Cancer Detect Prev",
      "key": "9690_CR27",
      "unstructured": "Damin A, Frazzon A, Damin D, Roehe A, Hermes V, Zettler C, Alexandre C (2006) Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detect Prev 30:523–529",
      "volume": "30",
      "year": "2006"
    },
    {
      "DOI": "10.1186/1471-2407-8-32",
      "author": "S Costa",
      "doi-asserted-by": "crossref",
      "first-page": "32",
      "journal-title": "BMC Cancer",
      "key": "9690_CR28",
      "unstructured": "Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F (2008) Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8:32",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1756-9966-28-115",
      "author": "W Zhuo",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "J Exp Clin Cancer Res",
      "key": "9690_CR29",
      "unstructured": "Zhuo W, Zhang Y, Xiang Z, Cai L, Chen Z (2009) Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res 28:115",
      "volume": "28",
      "year": "2009"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-013-9690-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "RAD51 135G\u0026gt;C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women"
  ],
  "type": "journal-article",
  "volume": "13"
}